Breaking News
March 23, 2019 - Excess hormones could cause a condition that can lead to blindness in women, study finds
March 23, 2019 - Dramatic shifts in first-time opioid prescriptions bring hope, concern
March 23, 2019 - Antidepressant drugs may not work when neurons are out of shape
March 23, 2019 - TTUHSC El Paso to establish endowed chair in neurology through a major grant
March 23, 2019 - New device approved by FDA for treating patients with moderate-to-severe heart failure
March 23, 2019 - People with peripheral artery disease have lower Omega-3 Index, shows research
March 23, 2019 - Trigger warnings have minimal impact on how people respond to content, shows research
March 23, 2019 - Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies
March 23, 2019 - Selfish genetic elements amplify inflammation and age-related diseases
March 23, 2019 - Study provides new understanding of how the brain recovers from damage caused by stroke
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
March 23, 2019 - CDC study shows modest improvement in optimal hospital breastfeeding policy
March 23, 2019 - Family-based prevention program to reduce alcohol use among older teens
March 23, 2019 - Remote monitoring of implanted defibrillators in heart failure patients prevents hospitalizations
March 23, 2019 - Appropriate doffing of personal protective equipment may reduce healthcare worker contamination
March 23, 2019 - Window screens can suppress mosquito populations, reduce malaria in Tanzania
March 23, 2019 - Researchers discover new biomarker for postoperative liver dysfunction
March 23, 2019 - Pregnancy history may be linked to cognitive function in older women, finds study
March 23, 2019 - Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack
March 23, 2019 - FDA Approves First Drug for Postpartum Depression, Zulresso (brexanolone)
March 23, 2019 - New guidelines outline new treatment management for psoriasis
March 23, 2019 - Thermally abused cooking oil may promote progression of breast cancer
March 23, 2019 - High-fructose corn syrup fuels growth of colon tumors in mice
March 23, 2019 - Partnership aims at establishing best practices to promote diversity in clinical trials
March 23, 2019 - New study examines presence of microbes in tap water from residences, office buildings
March 23, 2019 - Early life trauma may affect brain structure, contribute to major depressive disorder
March 23, 2019 - NIH starts clinical trial of drug to treat cravings associated with opioid use disorder
March 23, 2019 - Cervix bacteria, immune factors could be a warning signal of premature birth, reports new research
March 23, 2019 - Worst-ever emergency care performance figures underscore the need to focus on staffing
March 23, 2019 - The Current issue of “The view from here” is concerned with Cancer
March 23, 2019 - Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne
March 23, 2019 - Individual amygdala neurons respond to touch, imagery and sounds
March 23, 2019 - Combination of two topical creams can prevent cancer
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
March 23, 2019 - First-of-its-kind study provides pregnancy statistics of imprisoned U.S. women
March 23, 2019 - Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
March 23, 2019 - Laparoscopy: MedlinePlus Lab Test Information
March 23, 2019 - Shellfish allergies: can they be treated?
March 23, 2019 - Toilet seat heart monitoring system
March 23, 2019 - Researchers identify way to improve common treatment for PTSD
March 23, 2019 - High potency cannabis use linked to psychosis finds study
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
March 22, 2019 - Certain bacteria and immune factors in vagina may cause or protect against preterm birth
March 22, 2019 - Research identifies guidelines for prioritizing hepatitis C treatment in U.S. prisons
March 22, 2019 - Novel breath test could pave new way to non-invasively measure gut health
March 22, 2019 - Pharmaceutical and personal care products may result in new contaminants in waterways
March 22, 2019 - New model could revolutionize the way researchers investigate spread of pathogens
March 22, 2019 - MSU professor receives NSF CAREER grant for biosensor diagnostics
March 22, 2019 - High-fat, high-sugar diet in mouse mothers causes problems in the hearts of offspring
March 22, 2019 - ACC: Catheter Ablation Does Not Cut Mortality, Stroke in A-Fib
March 22, 2019 - Wiedemann-Rautenstrauch syndrome – Genetics Home Reference
March 22, 2019 - Health insurance is not assurance of healthcare
March 22, 2019 - Supporting “curiosity-driven research” at the Discovery Innovation Awards
March 22, 2019 - Must-Reads Of The Week (Some Flying Below The Radar)
March 22, 2019 - Newly engineered nanoscale protein micelles can be tracked by MRI
FIND launches new schistosomiasis program within neglected tropical diseases portfolio

FIND launches new schistosomiasis program within neglected tropical diseases portfolio

image_pdfDownload PDFimage_print

The Foundation for Innovative New Diagnostics (FIND) announced today the launch of a new schistosomiasis program within its neglected tropical diseases (NTD) portfolio. The program focuses on developing rapid diagnostic tests (RDTs) for detection of circulating anodic antigen (CAA) in blood and/or urine, to support national control and/or elimination programs in countries where schistosomiasis is regularly found.

Schistosomiasis is caused by parasitic worms carried by freshwater snails and affects over 206 million people across 78 tropical and sub-tropical countries, with most of the burden found in sub-Saharan Africa. People can become infected when they come into contact with fresh water that is infested with worm larvae, while carrying out routine activities. The infection triggers immune reactions resulting in progressive organ damage, which can lead to chronic ill-health and ultimately death, if left untreated. Current World Health Organization (WHO) guidelines for schistosomiasis diagnosis recommend examination of stool and/or urine samples by microscopy to detect worm eggs, but this can be challenging especially when the intensity of the infection is low. Analysis of multiple samples over several days by highly trained microscopists is both time-consuming and challenging to deploy; inaccurate diagnosis can lead to treatment being stopped too soon and, as a result, infections quickly returning to their original levels.

CAA is secreted continuously by living schistosomes. A laboratory-based test for the antigen, with high sensitivity for all species of schistosomes that are of public health importance, is available. However, in order to achieve optimal sensitivity, the test requires complex sample processing steps and a reader for detection.

FIND is leading a consortium, together with WHO, that includes Mologic, UK, and Leiden University Medical Center (LUMC), Netherlands, to develop novel RDTs for schistosomiasis infection. Two RDTs for CAA are being developed: one to support ongoing schistosomiasis control programs by providing data to estimate prevalence and intensity of infection, supporting the update of guidelines on routine use of RDTs for schistosomiasis; the other one with a higher sensitivity to support elimination efforts by identifying low infection intensities.

Initial work streams are being supported by catalytic funding from the Bill & Melinda Gates Foundation, with additional funding from Merck, through the Merck Global Health Institute, which is amongst the scientific partners of this program. The science and technology company Merck launched its Global Health Institute in April 2017 with the mission to develop transformative health solutions to support control and elimination programs related to infectious diseases such as schistosomiasis, and to contribute to the United Nations Sustainable Development Goals (SDGs).

Schistosomiasis is contracted from contaminated water, putting whole communities at risk. The new diagnostic technologies will be a huge step forward, but to achieve real impact their use cannot be confined to labs. The RDT format will allow testing in community settings and enable essential surveillance and disease tracking.”

Joseph Ndung’u, Head of Neglected Tropical Diseases at FIND

Contributing to the schistosomiasis control and elimination agenda is a priority for Merck. This program clearly addresses the need for new sensitive diagnostics in the fight against schistosomiasis.”

Beatrice Greco, Head of R&D and Access at the Merck Global Health Institute

Seven out of the 10 diseases identified in the London Declaration for eradication, elimination or control by 2020 lack critical diagnostic solutions – including schistosomiasis. With this addition to our neglected tropical diseases program, we are pleased to extend our long-standing commitment of bringing diagnostic excellence to the fight against these diseases, contributing to WHO goals for control and, ultimately, elimination.”

Catharina Boehme, CEO, FIND

The program to develop the CAA RDTs is expected to be complete within 4 years, with the first milestone of feasibility testing for the disease control test anticipated in 2019.

About author

Related Articles